7 unchanged sentences
Form of Common Stock Certificate.
+Added: Amendment No.
+Added: 3 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc.
+Added: and IDEAYA Biosciences, Inc.
+Added: dated as of August 9, 2021.
+Added: Amended and Restated Employment Agreement between Michael White and IDEAYA Biosciences, Inc.
+Added: effective as of October 25, 2021.
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
9 unchanged sentences
The cover page for the Company’s Quarterly Report on Form 10-Q has been formatted in Inline XBRL and contained in Exhibit 101
+Added: Certain information in this exhibit has been excluded pursuant to Regulation S-K, Item 601(b)(10).
+Added: Certain information in this exhibit has been excluded pursuant to Regulation S-K, Item 601(a)(6).
+Added: Indicates management contract or compensatory plan.
The certification attached as Exhibit 32.1 that accompanies this Quarterly Report on Form 10-Q is not deemed filed with the SEC and is not to be incorporated by reference into any filing of IDEAYA Biosciences, Inc.
2 unchanged sentences
IDEAYA Biosciences, Inc.
−Removed: August 10, 2021
+Added: November 15, 2021
/s/ Yujiro Hata
1 unchanged sentence
(Principal Executive Officer)
−Removed: August 10, 2021
+Added: November 15, 2021
/s/ Paul Stone, J.D.
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.